Promotion of Regular Oesophageal motility to Prevent regurgitation and Enhance nutrition intake in Long-stay ICU patients. A multicenter, Phase II, sham-controlled, randomized trial: The PROPEL Study
The PROPEL study represents an exciting collaboration between CERU and E-Motion Medical Ltd. to to assess the efficacy and safety of the E-Motion Systemâ„¢ on the promotion of GI motility in critically ill patients.
This study is intended to assess the efficacy and safety of the E-Motion System (i.e. E-Motion tubeTM and E-Motion EPG 1000TM) in improving tolerance to enteral nutrition by inducing esophageal motion by means of electrical stimulation in ICU patients.
This trial is registered at ClinicalTrials.gov (NCT02515123).